Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
about
Leptin-Induced JAK/STAT Signaling and Cancer GrowthOncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerγ-Secretase inhibitors and modulators.Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsThe integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exerciseThe Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and ProgressionMolecular cues on obesity signals, tumor markers and endometrial cancer.Leptin-Notch signaling axis is involved in pancreatic cancer progressionHistone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.NILCO biomarkers in breast cancer from Chinese patientsVisfatin promotes cell and tumor growth by upregulating Notch1 in breast cancerNotch inhibitors for cancer treatment.SIRT1 regulates endothelial Notch signaling in lung cancer.Leptin signaling molecular actions and drug target in hepatocellular carcinomaNotch-EGFR/HER2 Bidirectional Crosstalk in Breast CancerNew targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersDifferential effects of leptin and adiponectin in endothelial angiogenesis.Paracrine Interactions between Adipocytes and Tumor Cells Recruit and Modify Macrophages to the Mammary Tumor Microenvironment: The Role of Obesity and Inflammation in Breast Adipose TissueSuppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine ExpressionsLeptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cellsTargeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy.Multifaceted leptin network: the molecular connection between obesity and breast cancer.Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.Leptin's Pro-Angiogenic Signature in Breast CancerLeptin-cytokine crosstalk in breast cancer.A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.Leptin influences estrogen metabolism and increases DNA adduct formation in breast cancer cells.Obesity induced a leptin-Notch signaling axis in breast cancer.The Leptin Receptor Complex: Heavier Than Expected?The role IL-1 in tumor-mediated angiogenesis.Adipokine leptin in obesity-related pathology of breast cancer.Leptin and adiponectin: emerging therapeutic targets in breast cancer.Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.17 β-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway.Leptin-promoted human extravillous trophoblast invasion is MMP14 dependent and requires the cross talk between Notch1 and PI3K/Akt signaling.Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesisMelatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling.Downregulation of leptin inhibits growth and induces apoptosis of lung cancer cells via the Notch and JAK/STAT3 signaling pathways
P2860
Q26740512-D1209BCF-4E99-4953-ABD2-6F5B039F6ED1Q26750563-6A3912AD-3EA6-4903-87E3-E8089CA718CAQ26830462-FB1ED401-C135-4B3A-AA9C-47272BBD3E43Q26861403-A8FF728D-5335-4BBA-8E8E-C8B5E9D2E93EQ26861527-9B8E8D28-3165-4E06-9933-442AE5198D6CQ27004212-2D9DCEDC-E7D8-453E-8CAC-9206DC798834Q30372789-EB52F6E4-C071-4355-850E-818B6837C100Q30396675-B8AF4C49-5E76-458D-8080-6DD46895E02CQ33779854-E7829B2F-F388-433B-977D-8B42360D0B2FQ33808855-9EED1F64-8394-4A4E-BE84-041334C94F0EQ33914001-F00C4034-0E28-47A7-9755-223820C6D7AAQ34104148-0BC53B97-83C9-47DE-B1C0-525738664E74Q34330869-F5367015-61DD-4C68-9542-8AC5947D5B62Q34428786-8BC2B917-B3B7-419C-AEFC-A5C6BD716D06Q34548342-6E061AC3-82C0-4CC3-AE35-3570A6083798Q34686900-F9AED8F0-581C-46AB-ADE2-0BCE7061098BQ34706060-05D9CF1C-DF99-461A-9773-B868B8D5EF79Q35026566-A322D166-DD62-450E-8DD7-96AB5916FDD0Q35237496-76FB57F6-C4D6-4A81-87F2-77109FC82B8AQ35755120-08CC4E98-15C5-4E9F-9368-972FBC5CED29Q35868202-47D5DD13-D970-4EC6-B9F1-458A9BD508F8Q36213662-C6401CFD-B573-4AB9-9B84-147B60E06CB9Q36468606-313BF760-B79B-4C88-A4A2-1A5569D96A52Q36561207-9486D8F1-E7CD-4E03-9258-F0961278866DQ36738799-AECDB3EC-20C8-4220-9AB4-8535DA5C08B6Q37226530-1EB143DC-E503-4962-8805-1E0681D82CE8Q37351155-D660E0AB-A448-4CA1-8EF8-AA4830CA4CC5Q37411666-540982BB-FC07-4C1A-B1EC-1D8D6A634C66Q37596693-02E333ED-3BE6-45A1-9F6E-F80A5421A374Q37625788-03C21D1D-04B5-48A0-A454-3E801FB99E79Q37655073-313C9C79-0460-45A3-8863-FDC73481D60DQ37683553-E154DA6C-A2F7-4E4D-8452-E4ADAD122629Q38009725-8EECF30F-D917-447F-8212-A8BCCE193FDAQ38153628-0BB64968-7484-41FE-86F5-D521E7D0EFCFQ38221662-487C78F5-C6A9-4B6E-A695-20D3A220C9C2Q38766965-B4C3B6BE-C440-488E-B411-AAAE6ADAC875Q39020720-0D95F1B0-C6FB-4D89-818D-1733C689F5DBQ39032753-4AC94535-B374-4301-A123-416C23228934Q39393886-BCCD6923-2323-47DA-A328-1353A70E900FQ41828280-8038A177-AC05-432E-A84D-084FFBFE0C1D
P2860
Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@ast
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@en
type
label
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@ast
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@en
prefLabel
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@ast
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@en
P2860
P1433
P1476
Notch, IL-1 and leptin crossta ...... 2 expression in breast cancer.
@en
P2093
Ruben R Gonzalez-Perez
Shanchun Guo
P2860
P304
P356
10.1371/JOURNAL.PONE.0021467
P407
P577
2011-06-23T00:00:00Z